Substance Use Disorder: Treatment And Alternative Approaches To Pain Management Part I

14 Self-Paced Modules

  1. Introduction
  2. Opioid Counseling and Tapering
  3. Alternative Treatments for Pain Management
  4. Treatment Agreements
  5. Medical Cannabis
  6. Naloxone
  7. Emergency Department Response
  8. Defining Levels of Care
  9. Behavioral Approaches
  10. Medications for Substance Use Disorders
  11. Pain Management for the Patient in Recovery
  12. Support for Families and Loved Ones
  13. Needle Exchange Programs
  14. Conclusion

You must attend the full session and complete a post-test evaluation in order to receive credit. This program has been co-developed with the Pennsylvania Pharmacists Association.

Program Objectives

At the completion of this activity, the participant will be able to:

  • Provide patient counseling information associated with the prescribing/dispensing of an opioid prescription.
  • Explain the risk associated with equianalgesic dosing calculations.
  • List two recently suggested changes to the equianalgesic dosing table.
  • Identify symptoms of opioid withdrawal and describe a sensible approach to tapering opioids.
  • Differentiate among the different types of pain.
  • Identify six different non-opioid pain medications that can be used in the treatment of pain.
  • Describe six non-pharmacological interventions typically included in the pain management tool box.
  • Explain the role of the health care professional in the education of the patient experiencing acute and chronic pain and in the recommendation of pain management interventions.
  • Describe the purpose and utility of treatment agreements used with individuals who are prescribed opioids.
  • Identify the clinical environments in which treatment agreements are used.
  • Using the state of Pennsylvania as an example, explain the necessary components of a treatment agreement.
  • Discuss strategies for how violations of a treatment agreement can be handled.
  • Explain how treatment agreements can protect both patients and prescribers.
  • Discuss the legalities associated with cannabis in the U.S.
  • Describe the endocannabinoid system.
  • Discuss dosage forms, routes of administration, dosing guidelines, and adverse effects associated with medical cannabis.
  • Explore the evidence for cannabis use in pain and opioid use disorder.
  • Recognize the signs and symptoms of an opioid-induced breathing emergency.
  • Discuss the various naloxone delivery devices, their use, and adverse effects.
  • Describe the steps to properly manage an opioid-induced breathing emergency rescue.
  • Discuss methods for pharmacists to speak with patients about naloxone.
  • If given a patient case, identify potential toxidromes based upon signs and symptoms.
  • Compare the agents used to treat use disorders that commonly present to emergency departments.
  • Apply emergency department strategies to combat the opioid epidemic.
  • Describe the concept Continuum of Care.
  • Explain the American Society of Addiction Medicine (ASAM) assessment dimensions.
  • Differentiate the American Society of Addiction Medicine (ASAM) levels of care.
  • Describe the biopsychosocial approach to health.
  • Recognize substance abuse counseling techniques.
  • Apply counseling techniques to real world cases.
  • Discuss barriers to accessing FDA-approved pharmacotherapy for the treatment of opioid use disorder and other substance use disorders.
  • Summarize the use of pharmacotherapy for opioid withdrawal management.
  • Describe the use of pharmacotherapy for treatment of opioid use disorder.
  • Summarize the use of pharmacotherapy for alcohol withdrawal syndrome.
  • Describe the use of pharmacotherapy for treatment of alcohol use disorder.
  • Discuss pharmacotherapy options for treatment of other substance use disorders.
  • Review the role prescription opioids have within the opioid epidemic in the United States.
  • Identify the risks of under-treatment of acute pain in patients with opioid use disorder.
  • Discuss current acute pain management treatment recommendations for surgeries associated with mild-moderate pain vs. moderate-severe pain in patients with opioid use disorder.
  • Identify the risks of discontinuing buprenorphine/naloxone during the preoperative period.
  • Summarize opioid utilization for chronic pain management in patients with a history of opioid use disorder.
  • Describe substance use disorders as a family illness.
  • Provide examples of enabling and codependency behaviors.
  • Describe strategies that elicit behavior change including motivational interviewing, boundaries, natural consequences, healthy detachment, and self-care.
  • Identify support structures for family and loved ones.
  • Describe harm reduction.
  • Recognize the services provided by syringe services programs.
  • Reference available resources for syringe services program.

Accreditation Information

ACPEThe Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0159-0000-21-030-H08-P
Activity Type: Knowledge-based
Contact Hours: 12.00 or (1.2 CEU)
Release Date:3/05/2021
Expiration Date: 3/05/2024

Faculty

Janet Astle, B.S. Pharm., Ed.D.
Assistant Dean for Student Services
Duquesne University School of Pharmacy
Organizer

Bridget Calhoun, B.S., M.M.S., Dr.P.H.
Associate Dean for Academic Affairs and Research
Duquesne University Rangos School of Health Sciences

Jenna Carmichael, B.S. Biology, Pharm.D.
Clinical Pharmacist at Columbia Care
Owner, Wobbly Arrow Wellness
Adjunct Faculty at Wilkes University Nesbitt School of Pharmacy

Thomas S. Franko, Pharm.D.
Associate Professor Pharmacy Practice
Wilkes University Nesbitt School of Pharmacy

Holly C. Lassila, B.S. Pharm., Dr.P.H., M.S. Ed., LPC
Associate Professor Pharmacy Practice
Duquesne University School of Pharmacy

Michael Lynch, M.D.
UPMC Dept. of Emergency Medicine
Assistant Professor of Emergency Medicine, Toxicology, and Pediatrics
University of Pittsburgh School of Medicine

Mary Mihalyo, B.S. Pharm., Pharm.D., BCPS
CEO, Delta Care Rx
Adjunct Instructor
Duquesne University School of Pharmacy

Allison A. Morgan, MPA, PA-C
Assistant Professor/Academic Coordinator
Duquesne University

Daniel J. Ventricelli, Pharm.D., M.P.H.
Assistant Professor of Clinical Pharmacy
Philadelphia College of Pharmacy at University of the Sciences

David E. Zimmerman, Pharm.D., BCPS, BCCCP
Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy